Search research articles
Contact Us
Filters
Showing results (741-750 of 755) with videos related to
Page
of 76
Sort By:
JCI Insight
|
August 28, 2020
Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis
Johann E Gudjonsson, Lam C Tsoi, Feiyang Ma, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association
|
January 22, 2020
NAM Therapy-Evidence-Based Results
Elçin Esenlik, Travis Gibson, Serena Kassam, et al.
The Lancet. Infectious Diseases
|
September 12, 2024
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial
Victoria Harris, Jane Holmes, Oghenekome Gbinigie-Thompson, et al.
Nucleic Acids Research
|
October 30, 2014
RNAcentral: an international database of ncRNA sequences
, Anton I Petrov, Simon J E Kay, et al.
The New England Journal of Medicine
|
April 22, 2026
Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients
Christopher C Butler, Andrew D Pinto, Victoria Harris, et al.
Nature Communications
|
February 23, 2024
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients
Joseph F Standing, Laura Buggiotti, Jose Afonso Guerra-Assuncao, et al.
BMJ Open
|
August 7, 2023
Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease
Oghenekome Gbinigie, Emma Ogburn, Julie Allen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 4, 2000
Genome sequence of Halobacterium species NRC-1
W V Ng, S P Kennedy, G G Mahairas, et al.
Journal of Cheminformatics
|
March 27, 2015
The CHEMDNER corpus of chemicals and drugs and its annotation principles
Martin Krallinger, Obdulia Rabal, Florian Leitner, et al.
Clinical and Experimental Immunology
|
May 31, 2022
Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK
Adrian M Shields, Ariharan Anantharachagan, Gururaj Arumugakani, et al.
Page
of 76
Search research articles
Search
Showing results (741-750 of 755) with videos related to
Sort By:
Page
of 76
JCI Insight
|
August 28, 2020
Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis
Johann E Gudjonsson, Lam C Tsoi, Feiyang Ma, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association
|
January 22, 2020
NAM Therapy-Evidence-Based Results
Elçin Esenlik, Travis Gibson, Serena Kassam, et al.
The Lancet. Infectious Diseases
|
September 12, 2024
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial
Victoria Harris, Jane Holmes, Oghenekome Gbinigie-Thompson, et al.
Nucleic Acids Research
|
October 30, 2014
RNAcentral: an international database of ncRNA sequences
, Anton I Petrov, Simon J E Kay, et al.
The New England Journal of Medicine
|
April 22, 2026
Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients
Christopher C Butler, Andrew D Pinto, Victoria Harris, et al.
Nature Communications
|
February 23, 2024
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients
Joseph F Standing, Laura Buggiotti, Jose Afonso Guerra-Assuncao, et al.
BMJ Open
|
August 7, 2023
Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease
Oghenekome Gbinigie, Emma Ogburn, Julie Allen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 4, 2000
Genome sequence of Halobacterium species NRC-1
W V Ng, S P Kennedy, G G Mahairas, et al.
Journal of Cheminformatics
|
March 27, 2015
The CHEMDNER corpus of chemicals and drugs and its annotation principles
Martin Krallinger, Obdulia Rabal, Florian Leitner, et al.
Clinical and Experimental Immunology
|
May 31, 2022
Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK
Adrian M Shields, Ariharan Anantharachagan, Gururaj Arumugakani, et al.
Page
of 76